Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Автор: | Alim, Abdul |
---|---|
Інші автори: | Yasmin, Professor Dr. Hasina |
Формат: | Дисертація |
Мова: | English |
Опубліковано: |
Brac University
2023
|
Предмети: | |
Онлайн доступ: | http://hdl.handle.net/10361/18748 |
Схожі ресурси
-
A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
за авторством: Shehab, Habibul Mohsin
Опубліковано: (2024) -
Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
за авторством: Mahee, Sadique Abdal
Опубліковано: (2024) -
Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
за авторством: Chowdhury, Sariya Uzrat
Опубліковано: (2022) -
Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
за авторством: Tabassum, Nadira
Опубліковано: (2024) -
Role of protein’s and future treatment options for Alzheimer’s Disease
за авторством: Islam, Md. Irfath
Опубліковано: (2023)